Search
for
Sort by
Research 661–690 of 1000+
- Semaglutide Treatment of Excessive Body Weight in Obese PCOS Patients Unresponsive to Lifestyle Programs
- <i>Pseudomonas aeruginosa</i> heme metabolites biliverdin IXβ and IXδ are integral to lifestyle adaptations associated with chronic infection
- A Hybrid Transfer Learning Approach Using Obesity Data for Predicting Cardiovascular Diseases Incorporating Lifestyle Factors
- Investigating the role of obesity, circadian disturbances and lifestyle factors in people with schizophrenia and bipolar disorder: Study protocol for the SOMBER trial
- An Indian Evidence-Based Study of Prevalence, Phenotypic Features, Lifestyle Modifications of Polycystic Ovarian Syndrome Patients
- Metabolic dysfunction-associated steatotic liver disease is associated with androgenetic alopecia in adults with stronger effects in women and unhealthy lifestyles
- Collagen, Diet, and Lifestyle Disorders: Interactions Across Metabolic, Cardiovascular, Skin, Joint, and Gut Health
- Collagen, Diet, and Lifestyle Disorders: Interactions Across Metabolic, Cardiovascular, Skin, Joint, and Gut Health
- Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy
- Clinical, metabolic, and endocrine parameters in response to metformin and lifestyle intervention in women with polycystic ovary syndrome: A randomized, double-blind, and placebo control trial
- Scalp Bacterial Microbiota Dysbiosis in Androgenetic Alopecia: Community Structure, Functional Profiles, and Associations with Lifestyle Factors
- Scalp Microbiome Composition in Young Women: Associations with Scalp Type, Sensitivity, and Lifestyle Factors
- Supplemental Figures for "Adjunctive Therapies for Androgenetic Alopecia: A Clinical Review of Nutritional, Light-Based, Topical, and Lifestyle Approaches"
- Supplemental Figures for "Adjunctive Therapies for Androgenetic Alopecia: A Clinical Review of Nutritional, Light-Based, Topical, and Lifestyle Approaches"
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)
- Hidradenitis suppurativa: pathogenesis and management
- Pharma in the bedroom . . . and the kitchen. . . . The pharmaceuticalisation of daily life
- Symptom Monitoring and Dependent Care During Cancer Treatment in Children
- Ovarian Hypertension: Polycystic Ovary Syndrome
- THERAPY OF ENDOCRINE DISEASE: Treatment of hirsutism in the polycystic ovary syndrome
- Approach to the Management of Patients With Hidradenitis Suppurativa: A Consensus Document
- Adolescent Polycystic Ovary Syndrome
- Emerging concepts about prenatal genesis, aberrant metabolism and treatment paradigms in polycystic ovary syndrome
- Effect of body mass index (BMI) on phenotypic features of polycystic ovary syndrome (PCOS) in Singapore women: a prospective cross-sectional study
- An overview of unwanted female hair
- International PCOS guideline clinical research priorities roadmap: a co-designed approach aligned with end-user priorities in a neglected women’s health condition
- Targets to treat androgen excess in polycystic ovary syndrome
- Controversy: is there a role for adjuvants in the management of male pattern hair loss?
- Gender-specific risk factors for androgenetic alopecia in the Korean general population: Associations with medical comorbidities and general health behaviors
- Hirsutism in young women